I recently had the pleasure of joining Chris Hoff on The Radical Therapist Podcast. You can listen to our lively discussion about the 1960s, long-haired hippies, and mental health services during a period of big-time change. You can download the Pod here or through iTunes. Thanks for listening and sharing! #mentalhealthawareness #healthpolicy
The newest issue of Canadian HR Reporter discusses ‘weed in the workplace’ and focuses on drug screening. There are some vital ideas here about on-the-job safety, the legalities of drug testing, and impairment. Basically – drugs during ‘9 to 5.’ Also, I get my two cents in there! Check it out at Increasing use of marijuana could cause problems on the job
‘Dear Sir or Madam, will you read my book?
It took me years to write, will you take a look?
It’s based on a novel by a man named Lear
And I need a job, so I want to be a paperback writer
— The Beatles
I’m delighted to announce that my book – A Prescription for Scandal – is now available in paperback. Basically, it’s much cheaper. Please share and, hell, you might as well buy the book. If you’re interested in a discount, follow the link here Richert_Flyer_PBK and download the coupon.
And so on and so on!
Everyone knows someone or some story that reminds us of the incredible power of the pharmaceutical industry in our everyday lives. We see the advertisements during football games and food show. We see them in Men’s Health as well as Shape and Cosmo. The ads are everywhere. And by most accounts we’re consuming more and more pills every year.
For as long as I can remember I’ve had an interest in the pharmaceutical industry. My grandfather was a physician at Royal University Hospital and my mom was anti-Big Pharma through and through. So I definitely recall plenty of stimulating discussions around the supper table. At the same time I’ve always been intrigued by our influential neighbour to the south, the United States.
My new book, Conservatism, Consumer Choice and the FDA during the Reagan Era: A Prescription for Scandal, tries to understand the American drug industry in the era in which I grew up, the 1980s. Ronald Reagan was President. Dynasty, Dallas, and The Dukes of Hazard were on [the] tube. And I was caught up in G.I. Joes and my next soccer practice. Little did I know then that these were watershed years for pharmaceutical companies. But they were.
In writing this book, I tell a sometimes frightening story about how the regulation of Big Pharma got twisted, turned, and pulled upside down by politicians, consumer groups, and drug industry leaders. At the centre of this tug-of-war was the Food and Drug Administration, an independent government agency that was constantly under pressure during the 1980s. The stakes were extremely high. Lives were at stake. People’s health rested in the balance.
In 2016, these things haven’t really changed. We still need to make tough choices about the role prescription and non-prescription drugs play in society. Sure, the drug industry has done important things for our health, and yet it also has too much power and influence in our lives. I hear this all the time. I’m hopeful that my book can shed some light on how we’ve gotten to this point and help us think about the future.
Ewww. The business of body parts and body products? What? Sounds gruesome. Kinda grisly and macabre. But, as we discuss assisted suicide, selling plasma, or Canadian transplant tourists, in the media the way that we conceptualize the buying and selling our bodies will be vital.
Just like the poster for Daybreakers says, our bodies are a crucial “natural resource.” Hopefully not for a Vampire elite.
In the newest edition of the Canadian Bulletin for Medical History, I review Banking on the Body , which opens with an account of Connie Culp, the first American woman to undergo a face transplant after having been severely disfigured by a shotgun blast to the head. Yeah, a shotgun!
The groundbreaking surgery in 2008 included a new mouth, nose, and cheeks and, afterwards, Culp was once again able to talk, smile, and smell. It was a transformation of Culp’s appearance, her quality of life, and so much more.
For Kara W. Swanson, an Associate Professor of Law at Northeastern University, this procedure transformed all human faces and signified that it was “now a body product” to be “harvested from one body for use by another” (1). Culp’s story is one of medical ingenuity and ultimately positive, but it also fits within a larger history where “…the human body has become a source of property and value, as well as a source of hope to the dying and the disfigured” (2).
The book is really quite excellent. By examining human milk, blood, and semen, it clarifies how bodies and body products have been organized and exchanged in the United States over the past century. In doing so, Swanson highlights the significance of two interrelated concepts – the banking metaphor and the gift/commodity dichotomy – and provides lessons for Canadian policymakers.
In 1937, Dr Bernard Fantus of Cook County Hospital in Chicago borrowed the term bank from the world of money and markets to describe the process of stored blood in his hospital. Blood banks were a fresh way to think about maintaining the American blood supply and, not surprisingly, came under fire for the implied association between body products and money.
Yet, Fantus’s aim was not to promote commercial enterprises. Amid the toil and deprivation of the Great Depression, Fantus sought to “subvert the market allocation of blood solely to those who could afford to pay.” Cannily, “…by treating blood as money, he was trying to circumvent the need to pay money for blood” (7-8). The term bank proved resilient and the banking metaphor has grown as the dominant way of understanding the tradable value of “disembodied fluid,” as well as other body parts (7).
While the two hundredth anniversary of Mary Shelley’s Frankenstein inches closer and we continue to make advancements in the transplantation of human body parts, as in the case of Connie Culp, this sophisticated book has the potential to guide policy and frame future debates on bodies as both personal and civic property.
My review of Banking on the Body: The Market in Blood, Milk, and Sperm in Modern America can be read here.
Congrats on the new podcast! Check this out…
Points is incredibly excited to announce that our assistant managing editor Kyle Bridge and Alex Tepperman, PhD candidate in history at the University of Florida, have launched a new podcast called…
Today I wrote a short viewpoint for the Star Phoenix. The article is on medical cannabis for Canadian veterans.
Auditor General Michael Ferguson has raised important questions about the increasing use of medical marijuana by Canadian military veterans.
As authorities contemplate enforcement actions and zoning bylaws relevant to marijuana dispensaries, and the federal Liberal government prepares for legalization in 2017, Ferguson is urging the Department of Veterans Affairs to address the amount of medical cannabis being prescribed to veterans. He found the quantity prescribed was “poorly documented” and not always evidence-based.
Ferguson focused more broadly on how Veterans Affairs has been managing drug benefits for former servicemen and women, some of whom have complicated health issues and suffer from mental health conditions such as post-traumatic stress disorder. The AG made it plain that it’s time to cut through the haze and clarify marijuana policy for veterans.
The core problem rests with the amount of cannabis veterans are authorized to take. In 2014, Veterans Affairs doubled the amount to 10 grams per day for eligible veterans. Yet, for Health Canada this is twice the amount it considers safe. An internal Health Canada document showed that more than five grams has the potential to increase risks to the cardiovascular, pulmonary and immune systems, as well as psychomotor performance. It has a chance of increasing the risk of drug dependence.
Ferguson’s office could not find any evidence to support this decision to increase the threshold. Veterans Affairs Minister Kent Hehr expressed shock in March that his department lacked an “informed policy” on the use of medical cannabis, even as number of claims by veterans for medical marijuana grew more than tenfold over the past two years.
According to figures provided by Veterans Affairs, 112 veterans were reimbursed for medical marijuana in 2013-14, The following year, it was 628. By March 2016 that number has risen to 1,320.
Mike Blais, president and founder of Canadian Veterans Advocacy, has been abundantly clear about veterans’ consumption of medical marijuana: “I think there should be no cap, and that every case should be judged on individual merit and that the doctor’s prescription is paramount.”
At the same time, Canadian Forces have taken an alternative stand. In 2014, H.C. MacKay who was then the deputy surgeon general of the Canadian Forces, made clear that “with respect to marijuana use for medical purposes, we have identified what appears to be a very significant policy divergence between Veterans Affairs Canada and Canadian Armed Forces.”
In short, even though Veterans Affairs was funding medical marijuana, the military’s health service did not recognize it for medical use. With respect to PTSD, the Canadian Forces have also suggested there is insufficient evidence to authorize marijuana use and could even be detrimental to veterans’ health.
Marijuana remains a highly contested medicine for various scientific, political and social reasons. That is obvious. However, the auditor general report reaffirms how it and the policies surrounding the medical treatments for Canadian veterans require significant clarification.
Lucas Richert teaches the history of pharmaceutical and recreational drugs at the University of Saskatchewan.
Below the CBC covers the story.